Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 vs Lactulose in Mild Hepatic Encephalopathy
NCT00558038Phase 2Completed
- Sponsor
- Ocera Therapeutics
- Start
- Sep 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of activated charcoal in hepatic encephalopathy (HE), sponsored by Ocera Therapeutics. Started Sep 2007; status: completed.
02
Drugs
activated charcoal
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT00558038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558038.